NATIXIS

Position in NTRA — Natera, Inc.

CIK 1274981 PARIS, I0

Position in NTRA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$630,849

+$432,459 QoQ

Shares Held

2,324

+134.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#494

of 844 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NATIXIS holds $242,316,075 across 12 Diagnostics & Research names. NTRA ranks #11 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	241,128	$120,891,934
2	DHR	Danaher Corp /De/	381,030	$72,578,594
3	LH	Labcorp Holdings Inc.	53,983	$15,115,240
4	IDXX	Idexx Laboratories Inc /De	14,565	$7,667,598
5	MTD	Mettler Toledo International Inc/	5,315	$6,789,965
6	GRAL	GRAIL, Inc.	70,226	$4,794,329
7	DGX	Quest Diagnostics Inc	21,866	$4,634,498
8	A	Agilent Technologies, Inc.	32,579	$4,327,468

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$630,849	2,324	+134.3%	Shares	Sole	2026-08-13
2026-03-31	$198,390	992	-74.4%	Shares	Sole	2026-05-14
2025-12-31	$886,807	3,871	-38.1%	Shares	Sole	2026-02-13
2025-09-30	$1,006,223	6,251	+184.4%	Shares	Sole	2025-11-14
2025-03-31	$310,819	2,198	-72.2%	Shares	Sole	2025-07-18
2024-06-30	$855,166	7,897	-4.7%	Shares	Sole	2024-08-13
2024-03-31	$757,563	8,283	-48.2%	Shares	Sole	2024-05-13
2022-06-30	$567,040	16,000	-52.0%	Shares	Sole	2022-08-12
2022-03-31	$1,354,644	33,300	+256.1%	Shares	Sole	2022-05-13
2021-09-30	$1,042,186	9,352	-42.3%	Shares	Sole	2021-11-12
2021-06-30	$1,839,186	16,200	+54.3%	Shares	Sole	2021-08-13
2021-03-31	$1,066,170	10,500	-35.2%	Shares	Sole	2021-05-14
2020-12-31	$1,612,224	16,200	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.